Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
CleanSlate Centers in Kokomo, IN, specializes in outpatient care for individuals struggling with substance use disorders. This center offers personalized treatment plans for adults of all genders, incorporating medications like methadone, buprenorphine, or naltrexone. Through evidence-based techniques such as motivational interviewing, relapse prevention, and dedicated counseling, CleanSlate Centers crafts a unique recovery journey for each patient, fostering a supportive atmosphere committed to facilitating lasting sobriety.
CleanSlate Centers in Falmouth, MA, provides outpatient care for substance use disorders. They offer individualized treatment plans for adults and young adults, accommodating both men and women. Their approach incorporates evidence-based methods like motivational interviewing, relapse prevention strategies, and counseling to assist individuals in their recovery. CleanSlate Centers in Falmouth is dedicated to crafting personalized treatment that addresses the specific requirements of each person seeking support for addiction.
CleanSlate Centers in Tewksbury, MA, offers accessible outpatient care for individuals struggling with substance use disorders. Their approach centers on crafting personalized recovery plans for adults and young adults, incorporating medication-assisted treatment with options like methadone, buprenorphine, or naltrexone. This facility employs evidence-based methods including motivational interviewing, relapse prevention techniques, and dedicated counseling services to foster lasting sobriety. CleanSlate Centers in Tewksbury is committed to providing a supportive setting for both men and women, ensuring a tailored and effective treatment experience.
CleanSlate Centers in Richmond, IN, delivers outpatient services for individuals facing substance use challenges, emphasizing a personalized recovery path. This center extends outpatient methadone, buprenorphine, or naltrexone services to adults and young adults, irrespective of gender. Their therapeutic approach integrates motivational interviewing, relapse prevention techniques, and specialized counseling to bolster an individual's journey toward recovery. The distinctiveness of CleanSlate Centers in Richmond lies in its commitment to crafting treatment plans that address each client's specific circumstances, thereby setting it apart in addiction rehabilitation. For those in search of thorough and empathetic support for substance use disorders, this establishment is committed to delivering excellent care to foster enduring sobriety.
CleanSlate Centers in Fort Wayne, IN, provides outpatient care designed for adults and young adults facing substance use challenges. Their specialty lies in personalized treatment plans that incorporate motivational interviewing techniques, relapse prevention methods, and dedicated counseling for substance use disorders. The center offers medication-assisted treatment options, including methadone, buprenorphine, or naltrexone, to support recovery. CleanSlate Centers is committed to delivering high-quality support to both male and female individuals pursuing a path to lasting sobriety. For those desiring a tailored, research-backed recovery program, this location offers a promising solution.
CleanSlate Centers in Altoona, PA, provides outpatient services for individuals struggling with addiction. Their treatment options include medication-assisted treatment with methadone, buprenorphine, or naltrexone. They employ evidence-based therapies such as motivational interviewing, relapse prevention strategies, and counseling for substance use disorders. The center is dedicated to offering personalized care for adult men and women, fostering a recovery journey built on individual needs and quality support within a welcoming atmosphere.
CleanSlate Centers in Warsaw, IN, specializes in outpatient care for addiction, prioritizing personalized support. They offer medication-assisted treatment with methadone, buprenorphine, or naltrexone for adults and young adults, regardless of gender. Their program incorporates techniques like motivational interviewing, relapse prevention, and counseling to foster successful recovery. CleanSlate Centers is committed to providing excellent care adapted to the specific requirements of each person overcoming substance use challenges.
CleanSlate Medical Group of Kentucky, located in Bowling Green, provides outpatient treatment services for substance use disorders, featuring methadone/buprenorphine or naltrexone therapies. The center employs techniques such as motivational interviewing, relapse prevention, and personalized counseling for individuals facing addiction. Its approach is designed to cater to both adults and young adults, regardless of gender, ensuring a individualized care plan. CleanSlate Medical Group of Kentucky is recognized for its dedication to assisting individuals in conquering addiction in a safe and nurturing environment. Whether individuals are looking for help for themselves or someone they care about, this facility is committed to supporting their recovery journey.
CleanSlate Centers, located in Bethlehem, PA, provides outpatient treatment services for adults and young adults dealing with substance use issues. The center specializes in outpatient therapies including methadone, buprenorphine, and naltrexone, emphasizing motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders. Their personalized treatment plans are designed to meet the distinct needs of each individual. CleanSlate Centers features tailored programs for both men and women, ensuring a commitment to high-quality care for those on the path to recovery. If you or someone close to you is in search of thorough substance use treatment within a nurturing and supportive atmosphere, this center could be an excellent option for your healing process.
CleanSlate Centers in Williamsport, PA, provides accessible outpatient addiction treatment designed for adults and young adults. Their approach centers on personalized care, incorporating medication-assisted treatment with methadone, buprenorphine, or naltrexone. Complementing this are therapeutic interventions such as motivational interviewing, relapse prevention strategies, and dedicated substance use disorder counseling. The center caters to both male and female individuals, ensuring treatment plans are specifically adapted to their distinct requirements. CleanSlate Centers in Williamsport is recognized for its dedication to high-quality care and a thorough recovery methodology, distinguishing itself through tailored treatment and scientifically supported methods.
At CleanSlate Centers in New Bedford, MA, we provide specialized outpatient care for individuals battling substance use disorders, with a focus on methadone, buprenorphine, and naltrexone treatments. Our approach integrates motivational interviewing techniques, proven relapse prevention methods, and dedicated counseling services to foster lasting recovery. We are committed to offering tailored support for adult men and women, creating a secure and encouraging atmosphere where personalized treatment plans guide each person toward achieving and maintaining sobriety.
CleanSlate Centers in Alexandria, IN, provides accessible outpatient care for adults and young adults grappling with substance use disorders. Their approach centers on personalized treatment plans, incorporating medication-assisted treatment options like methadone, buprenorphine, or naltrexone. Evidence-based therapeutic techniques, including motivational interviewing, relapse prevention strategies, and individual counseling, are employed to foster lasting recovery. This facility is committed to offering a supportive and gender-inclusive space for all individuals embarking on their path to sobriety and a healthier future.
CleanSlate Centers, located in Waukesha, WI, specializes in outpatient treatment for substance use, emphasizing personalized care for adults and young adults. The facility offers outpatient services for methadone/buprenorphine and naltrexone, catering to both men and women. By employing motivational interviewing, strategies for preventing relapse, and counseling for substance use disorders, the center customizes its treatment plans to address the specific needs of each client. With a strong dedication to high-quality care, CleanSlate Centers distinguishes itself through its targeted approach and extensive services designed to assist individuals in their recovery journey.
CleanSlate Centers in Owensboro, KY, delivers outpatient care for substance use disorders, prioritizing personalized approaches. They offer outpatient medication-assisted treatment (methadone, buprenorphine, or naltrexone) for adults and young adults, serving all genders. Through techniques like motivational interviewing, relapse prevention planning, and counseling, this location customizes services to fit individual client requirements. Dedicated to high-quality support, CleanSlate Centers strives to assist individuals in their recovery process with thorough and empathetic addiction treatment.
CleanSlate Centers in Lafayette, IN, provides outpatient care for individuals battling substance use. Their program includes medication-assisted treatment with methadone, buprenorphine, or naltrexone, alongside specialized therapies like motivational interviewing, relapse prevention strategies, and counseling for substance use disorders. This facility offers a customized treatment experience for adults and young adults, ensuring that each person receives the attention needed to address their addiction. CleanSlate Centers in Lafayette, IN, is committed to aiding recovery through personalized, evidence-based support.
CleanSlate Centers in Bloomington, IN, provides accessible outpatient programs for individuals battling substance use disorders. Their services include medication-assisted treatment utilizing methadone, buprenorphine, or naltrexone. The center's expertise lies in employing techniques like motivational interviewing and relapse prevention strategies, alongside dedicated substance use disorder counseling. They are committed to delivering personalized care to adults and young adults, ensuring treatment plans are custom-designed to address each person's specific circumstances and recovery journey. CleanSlate Centers prioritizes a high standard of care, utilizing proven methods within a nurturing setting for those pursuing sobriety.
Cleanse Clinic in New Albany, Indiana provides outpatient substance use treatment with buprenorphine and naltrexone for young adults, adults, and seniors, including care for co-occurring serious mental illness. Medicare, Medicaid, private health insurance, and cash or self-payment are accepted.
CleanSlate Centers located in Leominster, MA, specializes in outpatient treatment for substance use disorders, offering methadone, buprenorphine, and naltrexone therapies. The center prioritizes motivational interviewing, strategies for preventing relapse, and counseling specifically for substance use issues. It provides customized treatment plans for both adults and young adults, addressing the needs of male and female clients alike. CleanSlate Centers is dedicated to a personalized care strategy, ensuring that patients receive top-notch treatment from skilled professionals within a nurturing atmosphere. For those in need of effective addiction recovery solutions, CleanSlate Centers in Leominster is an excellent option to support your healing process.
CleanSlate Centers in Wareham, MA, delivers outpatient care for addiction, centering on customized treatment plans for adults and young adults. This location offers personalized methadone/buprenorphine or naltrexone treatment. The program incorporates motivational techniques, relapse prevention methods, and addiction counseling to aid individuals in their recovery. By focusing on individual requirements, CleanSlate Centers provides a thorough treatment experience. This facility welcomes both male and female patients seeking high-quality, individualized assistance.
CleanSlate Centers in Milwaukee, WI, delivers community-based addiction treatment tailored to each individual's requirements. They specialize in outpatient programs for adults and young adults, incorporating medication-assisted treatment with options like methadone, buprenorphine, or naltrexone. Their therapeutic methods include motivational interviewing, relapse prevention techniques, and comprehensive counseling for substance use disorders. CleanSlate Centers in Milwaukee is committed to offering a personalized, evidence-based path to recovery for all clients.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.